Pfizer Inc. (PFE) NYSE
26.17
+0.03(+0.11%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
26.17
+0.03(+0.11%)
Currency In USD
| Market Cap | 141.5B |
| Enterprise Value | 207.77B |
| P/E Ratio | 19.88 |
| PEG Ratio | -3.45 |
| Price/Sales Ratio | 2.36 |
| Price/Book Ratio | 1.65 |
| Enterprise/Revenue | 3.35 |
| Enterprise/EBITDA | 12.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 29, 2026 |
| Profit Margin | 0.12 |
| Operating Margin | 0.23 |
| Return On Assets | 0.04 |
| Return On Equity | 0.08 |
| Revenue | 62.58B |
| Revenue/Share | 11.13 |
| Gross Profit | 44.01B |
| EBITDA | 15.1B |
| Net Income | 7.77B |
| Diluted EPS | 1.36 |
| Total Cash | 13.08B |
| Total Cash/Share | 2.3 |
| Total Debt | 64.46B |
| Total Debt/Equity | 0.72 |
| Current Ratio | 1.25 |
| Book Value Per Share | 15.89 |
| 52-Week Change | 11.41 |
| 52-Week High | 28.75 |
| 52-Week Low | 23.06 |
| Moving Average 50 Days | 26.76 |
| Moving Average 200 Days | 25.83 |
| Average Volume | 37.22M |
| Shares Outstanding | 5.7B |
| % Held by Institutions | 65.84 |
| Trailing Annual Dividend Rate | 1.72 |
| Trailing Annual Dividend Yield | 6.57 |
| Payout Ratio | 1.31 |
| Last Split Factor | 527:500 |
| Last Split Date | November 17, 2020 |